DARWIN EU® - Co-prescribing of endothelin receptor antagonists (ERAs) and phosphodiesterate-5 inhibitors (PDE-5is) in pulmonary arterial hypertension (PAH)

First published 07/08/2023

Last updated 25/09/2024

EU PAS number:

EUPAS106052

Study

Finalised

Documents

Study protocol

Initial protocol

Study Protocol P2 C1-003 Version 2.1 final

English (1.5 MB - PDF) View document

Study results

Study report

DARWIN EU_D2.2.4_Report_P2-C1-003_ERAS & PDE-5is in PAH_v2.1.pdf

English (2.16 MB - PDF) View document

Other information

Secondary tabs